111 related articles for article (PubMed ID: 21450937)
21. Risk of cancer of unknown primary after hospitalization for autoimmune diseases.
Hemminki K; Sundquist K; Sundquist J; Ji J
Int J Cancer; 2015 Dec; 137(12):2885-95. PubMed ID: 26103152
[TBL] [Abstract][Full Text] [Related]
22. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.
Friedman DL; Whitton J; Leisenring W; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL; Neglia JP
J Natl Cancer Inst; 2010 Jul; 102(14):1083-95. PubMed ID: 20634481
[TBL] [Abstract][Full Text] [Related]
23. Second cancers in patients with neuroendocrine tumors.
Tsai HJ; Wu CC; Tsai CR; Lin SF; Chen LT; Chang JS
PLoS One; 2013; 8(12):e86414. PubMed ID: 24392036
[TBL] [Abstract][Full Text] [Related]
24. Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?
van den Broek EC; Liu L; Posthuma EF; Janssen-Heijnen ML; Coebergh JW; Soerjomataram I
Ann Hematol; 2014 Jan; 93(1):157-62. PubMed ID: 24381068
[TBL] [Abstract][Full Text] [Related]
25. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
Rihani R; Bazzeh F; Faqih N; Sultan I
Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
[TBL] [Abstract][Full Text] [Related]
26. Risk of subsequent cancers in renal cell carcinoma survivors with a family history.
Chen T; Fallah M; Sundquist K; Liu H; Hemminki K
Eur J Cancer; 2014 Aug; 50(12):2108-18. PubMed ID: 24923229
[TBL] [Abstract][Full Text] [Related]
27. Kidney cancer in the Swedish Family Cancer Database: familial risks and second primary malignancies.
Czene K; Hemminki K
Kidney Int; 2002 May; 61(5):1806-13. PubMed ID: 11967031
[TBL] [Abstract][Full Text] [Related]
28. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035
[TBL] [Abstract][Full Text] [Related]
29. Risk of second primary neoplasm and mortality in childhood cancer survivors based on a national registry database.
Hayek S; Dichtiar R; Shohat T; Silverman B; Ifrah A; Boker LK
Cancer Epidemiol; 2018 Dec; 57():127-133. PubMed ID: 30399484
[TBL] [Abstract][Full Text] [Related]
30. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K
J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078
[TBL] [Abstract][Full Text] [Related]
31. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
Neglia JP; Robison LL; Stovall M; Liu Y; Packer RJ; Hammond S; Yasui Y; Kasper CE; Mertens AC; Donaldson SS; Meadows AT; Inskip PD
J Natl Cancer Inst; 2006 Nov; 98(21):1528-37. PubMed ID: 17077355
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of hyponatremia and increased risk of a subsequent cancer diagnosis: results from a nationwide population-based cohort study.
Holland-Bill L; Christiansen CF; Farkas DK; Donskov F; Jørgensen JOL; Sørensen HT
Acta Oncol; 2018 Apr; 57(4):522-527. PubMed ID: 28920509
[TBL] [Abstract][Full Text] [Related]
33. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.
Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Schootman M; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):727-737. PubMed ID: 30027284
[TBL] [Abstract][Full Text] [Related]
34. Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer - A national cohort study.
Waespe N; Belle FN; Redmond S; Schindera C; Spycher BD; Rössler J; Ansari M; Kuehni CE;
Eur J Cancer; 2021 Mar; 145():71-80. PubMed ID: 33423008
[TBL] [Abstract][Full Text] [Related]
35. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?
Hemminki K; Jiang Y; Steineck G
Eur J Cancer; 2003 Jan; 39(2):223-9. PubMed ID: 12509955
[TBL] [Abstract][Full Text] [Related]
36. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin.
Hemminki K; Dong C
Arch Dermatol; 2000 May; 136(5):647-51. PubMed ID: 10815858
[TBL] [Abstract][Full Text] [Related]
37. Risk of subsequent malignancies in survivors of childhood leukemia.
Perkins SM; Dewees T; Shinohara ET; Reddy MM; Frangoul H
J Cancer Surviv; 2013 Dec; 7(4):544-50. PubMed ID: 23749687
[TBL] [Abstract][Full Text] [Related]
38. Incidence of malignant tumours in patients with a non-functioning pituitary adenoma.
Olsson DS; Hammarstrand C; Bryngelsson IL; Nilsson AG; Andersson E; Johannsson G; Ragnarsson O
Endocr Relat Cancer; 2017 May; 24(5):227-235. PubMed ID: 28274953
[TBL] [Abstract][Full Text] [Related]
39. Risk of cancer of unknown primary among immigrants to Sweden.
Shu X; Sundquist K; Sundquist J; Hemminki K
Eur J Cancer Prev; 2012 Jan; 21(1):10-4. PubMed ID: 22044851
[TBL] [Abstract][Full Text] [Related]
40. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study.
Murphy JD; Ma GL; Baumgartner JM; Madlensky L; Burgoyne AM; Tang CM; Martinez ME; Sicklick JK
Cancer; 2015 Sep; 121(17):2960-7. PubMed ID: 25930983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
